BioVectra

BioVectra

A biotechnology company manufacturing therapeutic pharmaceuticals for treating cancer, kidney disease, cardiovascular disease, multiple sclerosis, and other diseases.

All edits

Edits on 9 February, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 9 February, 2020 7:03 am
Edits made to:
Article (+20/-20 characters)
Article

BioVectra is a biotechnology company manufacturing therapeutic pharmaceuticals for treating cancer, kidney disease, cardiovascular disease, multiple sclerosis, and other diseases that is headquartered in Charlottetown, Prince Edward IslandPrince Edward Island and was founded in 1970 by Dr. Regis Duffy. The company has the following capabilities to produce: microbial fermentation for active pharmaceutical ingredients, high potency active pharmaceutical ingredients, complex chemistry production, production of biologics, drug development, and process & analytical development.

Edits on 1 February, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 1 February, 2020 6:46 pm
Edits made to:
Article (+15/-15 characters)
Article

On March 12, 2019 BioVectra announced receiving $37.5 million from The Government of Canada's Strategic Innovation Fund. The investment was the largest investment made by the Strategic Innovation Fund in Atlantic CanadaAtlantic Canada. At the time of receiving funding, the company also announced a five year $144.6 million expansion project to increase the biopharmaceutical production capabilities of facilities in Charlottetown, Prince Edward Island and Windsor, Nova Scotia.

Edits on 30 September, 2019
Dawson Sewell
Dawson Sewell edited on 30 September, 2019 1:26 pm
Edits made to:
Description (+167 characters)
Article (+1086 characters)
Topic thumbnail

Biovectra BioVectra

A biotechnology company manufacturing therapeutic pharmaceuticals for treating cancer, kidney disease, cardiovascular disease, multiple sclerosis, and other diseases.

Article

BioVectra is a biotechnology company manufacturing therapeutic pharmaceuticals for treating cancer, kidney disease, cardiovascular disease, multiple sclerosis, and other diseases that is headquartered in Charlottetown, Prince Edward Island and was founded in 1970 by Dr. Regis Duffy. The company has the following capabilities to produce: microbial fermentation for active pharmaceutical ingredients, high potency active pharmaceutical ingredients, complex chemistry production, production of biologics, drug development, and process & analytical development.

Funding

The Government of Canada's Strategic Innovation Fund

On March 12, 2019 BioVectra announced receiving $37.5 million from The Government of Canada's Strategic Innovation Fund. The investment was the largest investment made by the Strategic Innovation Fund in Atlantic Canada. At the time of receiving funding, the company also announced a five year $144.6 million expansion project to increase the biopharmaceutical production capabilities of facilities in Charlottetown, Prince Edward Island and Windsor, Nova Scotia.

Edits on 8 July, 2019
Golden AI"Remove default description"
Golden AI edited on 8 July, 2019 9:48 pm
Edits made to:
Description (-7 characters)
Topic thumbnail

BioVectra

Company

Edits on 26 April, 2019
Umair Shah"Approved suggestion from source: http://www.biovectra.com/"
Umair Shah approved a suggestion from Golden's AI on 26 April, 2019 11:06 am
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 17 April, 2019
Golden AI
Golden AI edited on 17 April, 2019 12:41 pm
Edits made to:
Description (+7 characters)
Topic thumbnail

BioVectra

Company

Edits on 7 March, 2019
Golden AI
Golden AI edited on 7 March, 2019 10:11 pm
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 5 March, 2019
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 5 March, 2019 1:26 pm
Edits made to:
Infobox (+2 properties)
Infobox
Aime Anne Nisay"Initial topic creation"
Aime Anne Nisay created this topic on 5 March, 2019 1:26 pm
Edits made to:
Topic thumbnail

 Biovectra

A biotechnology company manufacturing therapeutic pharmaceuticals for treating cancer, kidney disease, cardiovascular disease, multiple sclerosis, and other diseases.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.